La maladie de Parkinson en France (serveur d'exploration) - Checkpoint (PubMed)

Index « Mesh.i » - entrée « Nerve Degeneration »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Nerve Block < Nerve Degeneration < Nerve Endings  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 68.
[20-40] [0 - 20][0 - 50][40-60]
Ident.Authors (with country if any)Title
000C22 (2008) Hervé Allain [France] ; Danièle Bentué-Ferrer ; Yvette AkwaDisease-modifying drugs and Parkinson's disease.
000C64 (2007) Vincent Paillé [France] ; Vincent Henry ; Laurent Lescaudron ; Philippe Brachet ; Philippe DamierRat model of Parkinson's disease with bilateral motor abnormalities, reversible with levodopa, and dyskinesias.
000C79 (2007) Laïla Amazzal [France] ; Agnès Lapôtre ; Frédéric Quignon ; Denyse BagrelMangiferin protects against 1-methyl-4-phenylpyridinium toxicity mediated by oxidative stress in N2A cells.
000C90 (2007) E C Hirsch [France]How to improve neuroprotection in Parkinson's disease?
000D66 (2006) Sandrine Greffard [France] ; Marc Verny ; Anne-Marie Bonnet ; Jean-Yves Beinis ; Claude Gallinari ; Sylvie Meaume ; François Piette ; Jean-Jacques Hauw ; Charles DuyckaertsMotor score of the Unified Parkinson Disease Rating Scale as a good predictor of Lewy body-associated neuronal loss in the substantia nigra.
000D71 (2006) A. Lannuzel [France] ; G U Höglinger ; P. Champy ; P P Michel ; E C Hirsch ; M. RubergIs atypical parkinsonism in the Caribbean caused by the consumption of Annonacae?
000D80 (2006) Mara Brizard [France] ; Carole Carcenac ; Alexis-Pierre Bemelmans ; Claude Feuerstein ; Jacques Mallet ; Marc SavastaFunctional reinnervation from remaining DA terminals induced by GDNF lentivirus in a rat model of early Parkinson's disease.
000E09 (2006) Erwan Bezard [France] ; Irene Gerlach ; Rosario Moratalla ; Christian E. Gross ; Reinhard Jork5-HT1A receptor agonist-mediated protection from MPTP toxicity in mouse and macaque models of Parkinson's disease.
000E69 (2005) S. Colnat-Coulbois [France] ; G C Gauchard ; L. Maillard ; G. Barroche ; H. Vespignani ; J. Auque ; Ph P. PerrinBilateral subthalamic nucleus stimulation improves balance control in Parkinson's disease.
000E88 (2004) Philippe Vernier [France] ; Frederic Moret ; Sophie Callier ; Marina Snapyan ; Christophe Wersinger ; Anita SidhuThe degeneration of dopamine neurons in Parkinson's disease: insights from embryology and evolution of the mesostriatocortical system.
000F55 (2003) E C Hirsch [France] ; T. Breidert ; E. Rousselet ; S. Hunot ; A. Hartmann ; P P MichelThe role of glial reaction and inflammation in Parkinson's disease.
000F57 (2003) Olga Corti [France] ; Cornelia Hampe ; Hana Koutnikova ; Frédéric Darios ; Sandrine Jacquier ; Annick Prigent ; Jean-Charles Robinson ; Laurent Pradier ; Merle Ruberg ; Marc Mirande ; Etienne Hirsch ; Thomas Rooney ; Alain Fournier ; Alexis BriceThe p38 subunit of the aminoacyl-tRNA synthetase complex is a Parkin substrate: linking protein biosynthesis and neurodegeneration.
000F80 (2003) Stephane Hunot [France] ; E C HirschNeuroinflammatory processes in Parkinson's disease.
000F93 (2003) Andreas Hartmann [France] ; Stéphane Hunot ; Etienne C. HirschInflammation and dopaminergic neuronal loss in Parkinson's disease: a complex matter.
001027 (2003) E C Hirsch [France] ; G. Höglinger ; E. Rousselet ; T. Breidert ; K. Parain ; J. Feger ; M. Ruberg ; A. Prigent ; C. Cohen-Salmon ; J M LaunayAnimal models of Parkinson's disease in rodents induced by toxins: an update.
001093 (2002) Y. Tsuboi [États-Unis] ; M. Baker ; M L Hutton ; R J Uitti ; O. Rascol ; M-B Delisle ; X. Soulages ; J R Murrell ; B. Ghetti ; M. Yasuda ; O. Komure ; S. Kuno ; K. Arima ; N. Sunohara ; T. Kobayashi ; Y. Mizuno ; Z K WszolekClinical and genetic studies of families with the tau N279K mutation (FTDP-17).
001150 (2001) S. Thobois [France] ; S. Guillouet ; E. BroussolleContributions of PET and SPECT to the understanding of the pathophysiology of Parkinson's disease.
001164 (2000) I. Ghorayeb [France] ; P O Fernagut ; I. Aubert ; E. Bezard ; Werner Poewe [Autriche] ; G K Wenning ; F. TisonToward a primate model of L-dopa-unresponsive parkinsonism mimicking striatonigral degeneration.
001181 (2000) E C Hirsch [France] ; S. HunotNitric oxide, glial cells and neuronal degeneration in parkinsonism.
001182 (2000) E C Hirsch [France]Nigrostriatal system plasticity in Parkinson's disease: effect of dopaminergic denervation and treatment.
001227 (2000) E. Bezard [France] ; M. Jaber ; F. Gonon ; A. Boireau ; B. Bloch ; C E GrossAdaptive changes in the nigrostriatal pathway in response to increased 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurodegeneration in the mouse.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/PubMed/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/Mesh.i -k "Nerve Degeneration" 
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/Mesh.i  \
                -Sk "Nerve Degeneration" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Nerve Degeneration
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024